Caspase-cleaved fragments of cytokeratin-18 as a marker of inflammatory activity in chronic hepatitis B virus infection

Journal of Clinical Virology

Volumn 58, Issue 4, 2013, Pages 641-646

  Bae, Chang Bum ^a   Kim, Soon Sun ^a   Ahn, Seun Joo ^a   Cho, Hyo Jung ^a   Kim, Sei Rhan ^a   Park, Sun Young ^a   Song, Ga Won ^a   Kim, Dong Joon ^b   Hwang, Seong Gyu ^c   Yang, Jin Mo ^d   Kim, Young Bae ^a   Park, Young Nyun ^e   Shin, Sung Jae ^a   Cho, Sung Won ^a   Cheong, Jae Youn ^a  

^a Ajou University School of Medicine   (South Korea)

^b Hallym University College of Medicine   (South Korea)

^c CHA University   (South Korea)

^d The Catholic University of Korea College of Medicine   (South Korea)

^e Yonsei University College of Medicine   (South Korea)

Author keywords

Apoptosis; Chronic hepatitis B; Cytokeratin 18; Inactive carrier; Significant inflammation

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; CASPASE; CYTOKERATIN 18; HEPATITIS B(E) ANTIGEN;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

APOPTOSIS; CHRONIC HEPATITIS B; CYTOKERATIN-18; INACTIVE CARRIER; SIGNIFICANT INFLAMMATION;

ADOLESCENT; ADULT; AGED; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; FEMALE; HEPATITIS B, CHRONIC; HUMANS; INFLAMMATION; KERATIN-18; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; ROC CURVE; YOUNG ADULT;

EID: 84888821054     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.10.008     Document Type: Article

References (27)

1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004, 11:97-107.
2. McMahon B.J. The natural history of chronic hepatitis B virus infection. Semin Liver Dis 2004, 24(Suppl. 1):17-21.
3. Suk K.T., Baik S.K., Yoon J.H., Cheong J.Y., Paik Y.H., Lee C.H., et al. Revision and update on clinical practice guideline for liver cirrhosis. Korean J Hepatol 2012, 18:1-21.
4. Hadziyannis S.J., Papatheodoridis G.V. Hepatitis B e antigen-negative chronic hepatitis B: natural history and treatment. Semin Liver Dis 2006, 26:130-141.
5. Manesis E.K., Papatheodoridis G.V., Sevastianos V., Cholongitas E., Papaioannou C., Hadziyannis S.J. Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection. Am J Gastroenterol 2003, 98:2261-2267.
6. Bantel H., Schulze-Osthoff K. Apoptosis in hepatitis C virus infection. Cell Death Differ 2003, 10(Suppl. 1):S48-S58.
7. Malhi H., Gores G.J., Lemasters J.J. Apoptosis and necrosis in the liver: a tale of two deaths?. Hepatology 2006, 43:S31-S44.
8. Galluzzi L., Maiuri M.C., Vitale I., Zischka H., Castedo M., Zitvogel L., et al. Cell death modalities: classification and pathophysiological implications. Cell Death Differ 2007, 14:1237-1243.
9. Omary M.B., Ku N.O., Toivola D.M. Keratins: guardians of the liver. Hepatology 2002, 35:251-257.
10. Oshima R.G. Apoptosis and keratin intermediate filaments. Cell Death Differ 2002, 9:486-492.
11. Linder S. Cytokeratin markers come of age. Tumour Biol 2007, 28:189-195.
12. Bantel H., Lugering A., Poremba C., Lugering N., Held J., Domschke W., et al. Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection. Hepatology 2001, 34:758-767.
13. Wieckowska A., Zein N.N., Yerian L.M., Lopez A.R., McCullough A.J., Feldstein A.E. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology 2006, 44:27-33.
14. Papatheodoridis G.V., Hadziyannis E., Tsochatzis E., Chrysanthos N., Georgiou A., Kafiri G., et al. Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection. Gut 2008, 57:500-506.
15. Lok A.S., McMahon B.J. Chronic hepatitis B: update 2009. Hepatology 2009, 50:661-662.
16. Wai C.T., Greenson J.K., Fontana R.J., Kalbfleisch J.D., Marrero J.A., Conjeevaram H.S., et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003, 38:518-526.
17. Vallet-Pichard A., Mallet V., Nalpas B., Verkarre V., Nalpas A., Dhalluin-Venier V., et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology 2007, 46:32-36.
18. Rust C., Gores G.J. Apoptosis and liver disease. Am J Med 2000, 108:567-574.
19. Bantel H., Lugering A., Heidemann J., Volkmann X., Poremba C., Strassburg C.P., et al. Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury. Hepatology 2004, 40:1078-1087.
20. Kronenberger B., Wagner M., Herrmann E., Mihm U., Piiper A., Sarrazin C., et al. Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C. J Viral Hepat 2005, 12:307-314.
21. Baumert T.F., Thimme R., von Weizsacker F. Pathogenesis of hepatitis B virus infection. World J Gastroenterol 2007, 13:82-90.
22. Brunetto M.R., Oliveri F., Coco B., Leandro G., Colombatto P., Gorin J.M., et al. Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study. J Hepatol 2002, 36:263-270.
23. Chen C.J., Yang H.I., Iloeje U.H. Hepatitis B virus DNA levels and outcomes in chronic hepatitis B. Hepatology 2009, 49:S72-S84.
24. Feld J.J., Ayers M., El-Ashry D., Mazzulli T., Tellier R., Heathcote E.J. Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B. Hepatology 2007, 46:1057-1070.
25. Eren F., Yilmaz Y., Kose S., Ozdemir F.T., Yonal O., Kurt R., et al. Caspase-cleaved fragments of cytokeratin 18 in patients with chronic hepatitis B. Clin Chim Acta 2010, 411:2029-2032.
26. Mohamadnejad M., Montazeri G., Fazlollahi A., Zamani F., Nasiri J., Nobakht H., et al. Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease. Am J Gastroenterol 2006, 101:2537-2545.
27. Cho H.J., Kim S.S., Ahn S.J., Bae C.B., Kim H.G., Kim Y.J., et al. Serum markers for predicting significant necroinflammatory activity in patients with chronic hepatitis B. Clin Biochem 2012, 45:1564-1567.